Cancer/testis-associated genes: Identification, expression profile, and putative function

Journal of Cellular Physiology

Volumn 194, Issue 3, 2003, Pages 272-288

  Zendman, Albert J W ^a   Ruiter, Dirk J ^a   Van Muijen, Goos N P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER GROWTH; CANCER IMMUNOTHERAPY; CELL LINEAGE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GERM CELL; HUMAN; MELANOCYTE; METHYLATION; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SPERMATOGENESIS; TESTIS; TRANSCRIPTION REGULATION; TUMOR GROWTH; X CHROMOSOME;

ANTIGENS, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; SKIN NEOPLASMS; SPERMATOGENESIS; TESTIS;

EID: 0037364292     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10215     Document Type: Review

References (183)

1. Aarnoudse CA, van den Doel PB, Heemskerk B, Schrier PI. 1999. Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-i, 1. Int J Cancer 82:442-448.
2. Aubry F, Satie AP, Rioux-Leclercq N, Rajpert-De Meyts E, Spagnoli GC, Chomez P, de Backer O, Jegou B, Samson M. 2001. MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer 92:2778-2785.
3. Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179:1005-1009.
4. Barker PA, Salehi A. 2002. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosei Res 67:705-712.
5. Bart J, Groen HJ, van der Graaf WT, Hollema H, Hendrikse NH, Vaalburg W, Sleijfer DT, de Vries EG. 2002. An oncological view on the blood-testis barrier. Lancet Oncol 3:357-363.
6. Boccaccio I, Glatt-Deeley H, Watrin F, Roeckel N, Lalande M, Muscatelli F. 1999. The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Hum Mol Genet 8:2497-2505.
7. Boel P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, van der Bruggen P. 1995. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2:167-175.
8. Boon T, van der Bruggen P. 1996. Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725-729.
9. Boon T, Cerottini JC, van den Eynde B, van der Bruggen P, van Pel A. 1994. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337-365.
10. Brinkmann U, Vasmatzis G, Lee B, Yerushalmi N, Essand M, Pastan I. 1998. PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus. Proc Natl Acad Sci USA 95:10757-10762.
11. Brinkmann U, Vasmatzis G, Lee B, Pastan I. 1999. Novel genes in the PAGE and GAGE family of tumor antigens found by homology walking in the dbEST database. Cancer Res 59:1445-1448.
12. Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA. 2000. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: Frequency of expression and correlation with prognostic parameters. Mod Pathol 13:459-465.
13. Chen YT, Boyer AD, Viars CS, Tsang S, Old LJ, Arden KC. 1997a. Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28. Cytogenet Cell Genet 79:237-240.
14. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ. 1997b. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94:1914-1918.
15. Chen ME, Lin SH, Chung LW, Sikes RA. 1998a. Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens. J Biol Chem 273:17618-17625.
16. Chen YT, Gure AO, Tsang S, Stockert E, Jager E, Knuth A, Old LJ. 1998b. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 95:6919-6923.
17. Cheville JC, Roche PC. 1999. MAGE-1 and MAGE-3 tumor rejection antigens in human germ cell tumors. Mod Pathol 12:974-978.
18. Chi DD, Merchant RE, Rand R, Conrad AJ, Garrison D, Turner R, Morton DL, Hoon DS. 1997. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas. Am J Pathol 150:2143-2152.
19. Cho B, Lim Y, Lee DY, Park SY, Lee H, Kim WH, Yang H, Bang YJ, Jeoung DI. 2002. Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem Biophys Res Commun 292:715-726.
20. Chomez P, Williams R, de Backer O, Boon T, Vennstrom B. 1996. The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation. Immunogenetics 43:97-100.
21. Chomez P, de Backer O, Bertrand M, de Plaen E, Boon T, Lucas S. 2001. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61:5544-5551.
22. Clark J, Rocques PJ, Crew AJ, Gill S, Shipley J, Chan AM, Gusterson BA, Cooper CS. 1994. Identification of novel genes, SYT and SSX, involved in the t(X;18)(pll.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 7:502-508.
23. Cormier JN, Hijazi YM, Abati A, Fetsch P, Bettinotti M, Steinberg SM, Rosenberg SA, Marincola FM. 1998. Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo. Int J Cancer 75:517-524.
24. Coulie PG, van den Eynde BJ, van der Bruggen P, van Pel A, Boon T. 1997. Antigens recognized by T-lymphocytes on human tumours. Biochem Soc Trans 25:544-548.
25. Dabovic B, Zanaria E, Bardoni B, Lisa A, Bordignon C, Russo V, Matessi C, Traversari C, Camerino G. 1995. A family of rapidly evolving genes from the sex reversal critical region in Xp21. Mamm Genome 6:571-580.
26. Dalerba P, Ricci A, Russo V, Rigatti D, Nicotra MR, Mottolese M, Bordignon C, Natali PG, Traversari C. 1998. High homogeneity of MAGE, BAGE, GAGE, tyrosinase and Melan-A/MART-1 gene expression in clusters of multiple simultaneous metastases of human melanoma: Implications for protocol design of therapeutic antigen-specific vaccination strategies. Int J Cancer 77:200-204.
27. de Backer O, Arden KC, Boretti M, Vantomme V, de Smet C, Czekay S, Viars CS, de Plaen E, Brasseur F, Chomez P, van den Eynde B, Boon T, van der Bruggen P. 1999. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res 59:3157-3165.
28. de Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, de Smet C, Brasseur F, van der Bruggen P, Lethe B, Lurquin C, et al. 1994. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40:360-369.
29. de Plaen E, de Backer O, Arnaud D, Bonjean B, Chomez P, Martelange V, Avner P, Baldacci P, Babinet C, Hwang SY, Knowles B, Boon T. 1999. A new family of mouse genes homologous to the human MAGE genes. Genomics 55:176-184.
30. de Rooij DG. 1998. Stem cells in the testis. Int J Exp Pathol 79:67-80.
31. de Smet C, Courtois SJ, Faraoni I, Lurquin C, Szikora JP, de Backer O, Boon T. 1995. Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics 42:282-290.
32. de Smet C, de Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. 1996. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 93:7149-7153.
33. de Smet C, Lurquin C, Lethe B, Martelange V, Boon T. 1999. DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 19:7327-7335.
34. de Vries TJ, Fourkour A, Wobbes T, Verkroost G, Ruiter DJ, van Muijen GNP. 1997. Heterogeneous expression of immunotherapy candidate proteins gp100, MART1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer Res 57:3223-3229.
35. de Wit NJ, Weidle UH, Ruiter DJ, van Muijen GN. 2002. Expression profiling of MMA-1a and splice variant MMA-1b: New cancer/testis antigens identified in human melanoma. Int J Cancer 98:547-553.
36. Debinski W, Gibo DM. 2000. Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen. Mol Med 6:440-449.
37. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD. 1996. Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Proe Natl Acad Sci USA 93:6025-6030.
38. dos Santos NR, de Bruijn DR, Balemans M, Janssen B, Gartner F, Lopes JM, de Leeuw B, Geurts van Kessel A. 1997. Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins. Hum Mol Genet 6:1549-1558.
39. dos Santos NR, de Bruijn DR, Kater BE, Otte AP, Geurts van Kessel A. 2000. Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization. Exp Cell Res 256: 192-202.
40. dos Santos NR, Torensma R, de Vries TJ, Schreurs MWJ, de Bruijn DRH, Kater BE, Ruiter DJ, Adema GJ, van Muijen GNP, Geurts van Kessel A. 2000. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res 60:1654-1662.
41. Duan Z, Feller AJ, Toh HC, Makastorsis T, Seiden MV. 1999. TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line. Gene 229:75-81.
42. Eddy EM. 1998. Regulation of gene expression during spermatogenesis. Semin Cell Dev Biol 9:451-457.
43. Eichmuller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D. 2001. Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci USA 98:629-634.
44. Esteller M, Herman JG. 2002. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196:1-7.
45. Feller AJ, Duan Z, Penson R, Toh HC, Seiden MV. 2000. TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma. Anticancer Res 20: 4147-4151.
46. Fiszer D, Kurpisz M. 1998. Major histocompatibility complex expression on human, male germ cells: A review. Am J Reprod Immunol 40:172-176.
47. Garcia LA, Algarra I, Gaforio JJ, Ruiz CF, Garrido F. 2001. Immunoselection by T lymphocytes generates repeated mhc class I-deficient metastatic tumor variants. Int J Cancer 91:109-119.
48. Gillespie AM, Coleman RE. 1999. The potential of melanoma antigen expression in cancer therapy. Cancer Treat Rev 25:219-227.
49. Goydos JS, Patel M, Shih WC. 2001. NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma. J Surg Res 98: 76-80.
50. Green DR, Ferguson TA. 2001. The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol 2:917-924.
51. Gure AO, Tureci O, Sahin U, Tsang S, Scanlan MJ, Jager E, Knuth A, Pfreundschuh M, Old LJ, Chen YT. 1997. SSX: A multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 72:965-971.
52. Gure AO, Stockert E, Arden KC, Boyer AD, Viars CS, Scanlan MJ, Old LJ, Chen YT. 2000. CT10: A new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer 85:726-732.
53. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini JC, Tschopp JRA. 1996. Melanoma cell expression of Fas (apo 1/cd95) ligand: Implications for tumor immune escape. Science 274:1363-1366.
54. Hendriksen PJ. 1999. Do X and Y spermatozoa differ in proteins? Theriogenology 52:1295-1307.
55. Herlyn M. 2002. Emerging concepts and technologies in melanoma research. Melanoma Res 12:3-8.
56. Hofbauer GF, Schaefer C, Noppen C, Boni R, Kamarashev J, Nestle FO, Spagnoli GC, Dummer R. 1997. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: Frequency and distribution. Am J Pathol 151:1549-1553.
57. Houghton AN, Gold JS, Blachere NE. 2001. Immunity against cancer: Lessons learned from melanoma. Curr Opin Immunol 13:134-140.
58. Huang S, Spector DL. 1992. U1 and U2 small nuclear RNAs are present in nuclear speckles. [published erratum appears in Proc Natl Acad Sci USA 1992 May. Proc Natl Acad Sci USA 1:305-308.
59. Hubank M, Schatz DG. 1994. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 22:5640-5648.
60. Igney FH, Krammer PH. 2002. Immune escape of tumors: Apoptosis resistance and tumor counterattack. J Leukoc Biol 71:907-920.
61. Ikeda H, Lethe B, Lehmann F, van Baren N, Baurain JF, de Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG. 1997. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6:199-208.
62. Jager E, Ringhoffer M, Altmannsberger M, Arand M, Karbach J, Jager D, Oesch F, Knuth A. 1997. Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int J Cancer 71:142-147.
63. Jager E, Gnjatic S, Nagata Y, Stockert E, Jager D, Karbach J, Neumann A, Rieckenberg J, Chen YT, Ritter G, Hoffman E, Arand M, Old LJ, Knuth A. 2000. Induction of primary NY-ESO-1 immunity: CD8+T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+cancers. Proc Natl Acad Sci USA 97:12198-12203.
64. Jager D, Unkelbach M, Frei C, Bert F, Scanlan MJ, Jager E, Old LJ, Chen YT, Knuth A. 2002. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun 2:5-11.
65. Janssen BL, van de Locht LT, Fourkour A, de Smet C, Mensink EJ, van Muijen GN, de Vries TJ. 1999. Transcription of the MAGE-1 gene and the methylation status of its Ets binding promoter elements: A quantitative analysis in melanoma cell lines using a real-time polymerase chain reaction technique. Melanoma Res 9:213-222.
66. Jassim A, Ollier W, Payne A, Biro A, Oliver RT, Festenstein H. 1989. Analysis of HLA antigens on germ cells in human semen. Eur J Immunol 19:1215-1220.
67. Jay P, Rougeulle C, Massacrier A, Moncla A, Mattei MG, Malzac P, Roeckel N, Taviaux S, Lefranc JL, Cau P, Berta P, Lalande M, Muscatelli F. 1997. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet 17:357-361.
68. Jones PA. 1999. The DNA methylation paradox. Trends Genet 15:34-37.
69. Jones MH, Numata M, Shimane M. 1997. Identification and characterization of BRDT: A testis-specific gene related to the bromo-domain genes RING3 and Drosophila fsh. Genomics 45:529-534.
70. Jungbluth AA, Busam KJ, Kolb D, Iversen K, Coplan K, Chen YT, Spagnoli GC, Old LJ. 2000a. Expression of MAGE-antigens in normal tissues and cancer. Int J Cancer 85:460-465.
71. Jungbluth AA, Stockert E, Chen YT, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Busam KJ, Old LJ. 2000b. Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer 83:493-497.
72. Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ. 2001. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 92:856-860.
73. Jungbluth AA, Chen YT, Busam KJ, Coplan K, Kolb B, Iversen K, Williamson B, van Landeghem FK, Stockert E, Old LJ. 2002. CT7 (MAGE-C1) antigen expression in normal and neoplastic tissues. Int J Cancer 99:839-45.
74. Kamarashev J, Ferrone S, Seifert B, Boni R, Nestle FO, Burg G, Dummer R. 2001. TAP1 down-regulation in primary melanoma lesions: An independent marker of poor prognosis. Int J Cancer 95:23-28.
75. Kawakami Y, Robbins PF, Wang X, Tupesis JP, Parkhurst MR, Kang X, Sakaguchi K, Appella E, Rosenberg SA. 1998. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. J Immunol 161:6985-6992.
76. Kawano Y, Sasaki M, Nakahira K, Yoshimine T, Shimizu K, Wada H, Ikenaka K. 2001. Structural characterization and chromosomal localization of the MAGE-E1 gene. Gene 277:129-137.
77. Kirkin AF, Dzhandzhugazyan KN, Zeuthen J. 2002. Cancer/testis antigens: Structural and immunobiological properties. Cancer Invest 20:222-236.
78. Kleene KC. 2001. A possible meiotic function of the peculiar patterns of gene expression in mammalian spermatogenic cells. Mech Dev 106:3-23.
79. Kocher T, Schultz TE, Gudat F, Schaefer C, Casorati G, Juretic A, Willimann T, Harder F, Heberer M, Spagnoli GC. 1995. Identification and intracellular location of MAGE-3 gene product. Cancer Res 55:2236-2239.
80. Kondoh N, Nishina Y, Tsuchida J, Koga M, Tanaka H, Uchida K, Inazawa J, Taketo M, Nozaki M, Nojima H, Matsumiya K, Namiki M, Okuyama A, Nishimune Y. 1997. Assignment of synaptonemal complex protein 1 (SCP1) to human chromosome lp13 by fluorescence in situ hybridization and its expression in the testis. Cytogenet Cell Genet 78:103-104.
81. Kurnick JT, Ramirez-Montagut T, Boyle LA, Andrews DM, Pandolfi F, Durda PJ, Butera D, Dunn IS, Benson EM, Gobin SJ, van den Elsen PJ. 2001. A novel autocrine pathway of tumor escape from immune recognition: Melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A/MART-1 antigen through down-modulation of its promoter. J Immunol 167:1204-1211.
82. Lacy HM, Sanderson RD. 2001. Sperm protein 17 is expressed on normal and malignant lymphocytes and promotes heparan sulfate-mediated cell-cell adhesion. Blood 98:2160-2165.
83. Landry C, Brasseur F, Spagnoli GC, Marbaix E, Boon T, Coulie P, Godelaine D. 2000. Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int J Cancer 86:835-841.
84. Langnaese K, Kloos DU, Wehnert M, Seidel B, Wieacker P. 2001. Expression pattern and further characterization of human MAGED2 and identification of rodent orthologues. Cytogenet Cell Genet 94:233-240.
85. Lethe B, Lucas S, Michaux L, de Smet C, Godelaine D, Serrano A, de Plaen E, Boon T. 1998. LAGE-1, a new gene with tumor specificity. Int J Cancer 76:903-908.
86. Liang P, Pardee AB. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction [see comments]. Science 257:967-971.
87. Lim FL, Soulez M, Koczan D, Thiesen HJ, Knight JC. 1998. A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 17:2013-2018.
88. Lim SH, Wang Z, Chiriva-Internati M, Xue Y. 2001. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood 97: 1508-1510.
89. Lin C, Mak S, Meitner PA, Wolf JM, Bluman EM, Block JA, Terek RM. 2002. Cancer/testis antigen CSAGE is concurrently expressed with MAGE in chondrosarcoma. Gene 285:269-278.
90. Liu XF, Helman LJ, Yeung C, Bera TK, Lee B, Pastan I. 2000a. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma. Cancer Res 60:4752-4755.
91. Liu Y, Black J, Kisiel N, Kulesz-Martin MF. 2000b. SPAF, a new AAA-protein specific to early spermatogenesis and malignant conversion. Oncogene 19:1579-1588.
92. Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I, Mannan P, Larsson E, Kanduri C, Vostrov AA, Cui H, Niemitz EL, Rasko JE, Docquier FM, Kistler M, Breen JJ, Zhuang Z, Quitschke WW, Renkawitz R, Klenova EM, Feinberg AP, Ohlsson R, Morse HC III, Lobanenkov VV. 2002. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same ll-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci USA 99:6806-6811.
93. Lucas S, de Smet C, Arden KC, Viars CS, Lethe B, Lurquin C, Boon T. 1998. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 58: 743-752.
94. Lucas S, Brasseur F, Boon T. 1999. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells. Cancer Res 59:4100-4103.
95. Lucas S, de Plaen E, Boon T. 2000. MAGE-B5, MAGE-B6, MAGE-C2, and MAGE-C3: Four new members of the MAGE family with tumor-specific expression. Int J Cancer 87:55-60.
96. Lurquin C, de Smet C, Brasseur F, Muscatelli F, Martelange V, de Plaen E, Brasseur R, Monaco AP, Boon T. 1997. Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46:397-408.
97. Ma Z, Khatlani TS, Ohno K, Sasaki K, Inokuma H, Onishi T. 2000. Cloning and sequencing of canine MAGE cDNA. Tissue Antigens 56:166-169.
98. Ma Z, Khatlani TS, Sasaki K, Okuda M, Inokuma H, Onishi T. 2002. Molecular cloning and sequencing of feline melanoma antigen 2 (fMAGE-2) obtained from a lymphoma cell line. Tissue Antigens 59:127-132.
99. Marchand M, van Baren N, Weynants P, Brichard V, Dreno B, Tessier MH, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R, Lienard D, Beauduin M, Dietrich PY, Russo V, Kerger J, Masucci G, Jager E, de Greve J, Atzpodien J, Brasseur F, Coulie PG, van der Bruggen P, Boon T. 1999. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 80:219-230.
100. Marks MS, Seabra MC. 2001. The melanosome: Membrane dynamics in black and white. Nat Rev Mol Cell Biol 2:738-748.
101. Martelange V, de Smet C, de Plaen E, Lurquin C, Boon T. 2000. Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res 60:3848-3855.
102. Matera AG. 1999. Nuclear bodies: Multifaceted subdomains of the interchromatin space. Trends Cell Biol 9:302-309.
103. Mayrand SM, Green WR. 1998. Non-traditionally derived CTL epitopes: Exceptions that prove the rules? Immunol Today 19:551-556.
104. McCurdy DK, Tai LQ, Nguyen J, Wang Z, Yang HM, Udar N, Naiem F, Concannon P, Gatti RA. 1998. MAGE Xp-2: A member of the MAGE gene family isolated from an expression library using systemic lupus erythematosus sera. Mol Genet Metab 63:3-13.
105. Meuwissen RL, Offenberg HH, Dietrich AJ, Riesewijk A, van Iersel M, Heyting C. 1992. A coiled-coil related protein specific for synapsed regions of meiotic prophase chromosomes. EMBO J 11:5091-5100.
106. Miller AP, Willard HF. 1998. Chromosomal basis of X chromosome inactivation: Identification of a multigene domain in Xp11.21-p11.22 that escapes X inactivation. Proc Natl Acad Sci USA 95: 8709-8714.
107. Mintz A, Debinski W. 2000. Cancer genetics/epigenetics and the X chromosome: Possible new links for malignant glioma pathogenesis and immune-based therapies. Crit Rev Oncog 11:77-95.
108. Mitchell PJ, Tjian R. 1989. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245:371-378.
109. Moreau-Aubry A, Le Guiner S, Labarriere N, Gesnel MC, Jotereau F, Breathnach R. 2000. A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma. J Exp Med 191:1617-1624.
110. Muscatelli F, Walker AP, de Plaen E, Stafford AN, Monaco AP. 1995. Isolation and characterization of a MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci USA 92:4987-4991.
111. Nagai H, Kim YS, Yasuda T, Ohmachi Y, Yokouchi H, Monden M, Emi M, Konishi N, Nogami M, Okumura K, Matsubara K. 1999. A novel sperm-specific hypomethylation sequence is a demethylation hot-spot in human hepatocellular carcinomas. Gene 237:15-20.
112. Neugebauer KM, Roth MB. 1997. Distribution of pre-mRNA splicing factors at sites of RNA polymerase II transcription. Genes Dev 11: 1148-1159.
113. Nieto MA, Simpson P. 2002. Editorial overview: Gene families and developmental diversity. Curr Opin Genet Dev 12:383-385.
114. O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F. 1999. The Fas counterattack: Cancer as a site of immune privilege. Immunol Today 20:46-52.
115. Ohman F, Nordqvist K. 2001. The melanoma antigen genes - any clues to their functions in normal tissues? Exp Cell Res 265:185-194.
116. Ohnmacht GA, Marincola FM. 2000. Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma. J Cell Physiol 182:332-338.
117. Old LJ. 2001. Cancer/testis (CT) antigens - A new link between gametogenesis and cancer. Cancer Immun 1:1-7.
118. Old LJ, Chen YT. 1998. New paths in human cancer serology [comment]. J Exp Med 187:1163-1167.
119. Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, Aoe M, Nakamura S, Higashi T, Hiraki A, Wada H, Kumon H, Old LJ, Nakayama E. 2001. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci USA 98:3282-3287.
120. Park JH, Lee SW. 2002. Hypertonicity induction of melanoma antigen, a tumor-associated antigen. Mol Cells 13:288-295.
121. Pold M, Zhou J, Chen GL, Hall JM, Vescio RA, Berenson JR. 1999. Identification of a new, unorthodox member of the MAGE gene family. Genomics 59:161-167.
122. Rammensee HG. 1995. Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol 7:85-96.
123. Renkvist N, Castelli C, Robbins PF, Parmiani G. 2001. A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 50:3-15.
124. Rimoldi D, Salvi S, Reed D, Coulie P, Jongeneel VC, de Plaen E, Brasseur F, Rodriguez AM, Boon T, Cerottini JC. 1999. cDNA and protein characterization of human MAGE-10. Int J Cancer 82:901-907.
125. Rimoldi D, Rubio GV, Dutoit V, Lienard D, Salvi S, Guillaume P, Speiser D, Stockert E, Spagnoli G, Servis C, Cerottini JC, Lejeune F, Romero P, Valmori D. 2000a. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma. J Immunol 165:7253-7261.
126. Rimoldi D, Salvi S, Schultz TE, Spagnoli GC, Cerottini JC. 2000b. Anti-MAGE-3 antibody 57B and anti-MAGE-1 antibody 6C1 can be used to study different proteins of the MAGE-A family [letter]. Int J Cancer 86:749-751.
127. Robbins PF, El Gamil M, Li YF, Topalian SL, Rivoltini L, Sakaguchi K, Appella E, Kawakami Y, Rosenberg SA. 1995. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24-restricted tumor-infiltrating lymphocytes. J Immunol 154:5944-5950.
128. Robbins PF, El Gamil M, Li YF, Kawakami Y, Loftus D, Appella E, Rosenberg SA. 1996. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med 183:1185-1192.
129. Robertson KD, Jones PA. 2000. DNA methylation: Past, present and future directions. Carcinogenesis 21:461-467.
130. Robertson KD, Wolffe AP. 2000. DNA methylation in health and disease. Nat Rev Genet 1:11-19.
131. Rogner UC, Wilke K, Steck E, Korn B, Poustka A. 1995. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics 29:725-731.
132. Rosenberg SA. 1999. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10:281-287.
133. Saburi S, Nadano D, Akama TO, Hirama K, Yamanouchi K, Naito K, Tojo H, Tachi C, Fukuda MN. 2001. The trophinin gene encodes a novel group of MAGE proteins, magphinins, and regulates cell proliferation during gametogenesis in the mouse. J Biol Chem 276: 49378-49389.
134. Sage J, Martin L, Cuzin F, Rassoulzadegan M. 1995. cDNA sequence of the murine synaptonemal complex protein 1 (SCP1). Biochim Biophys Acta 1263:258-260.
135. Sahin U, Tureci O, Pfreundschuh M. 1997. Serological identification of human tumor antigens. Curr Opin Immunol 9:709-716.
136. Sahin U, Tureci O, Chen YT, Seitz G, Villena HC, Old LJ, Pfreundschuh M. 1998. Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies [letter]. Int J Cancer 78:387-389.
137. Sahin U, Koslowski M, Tureci O, Eberle T, Zwick C, Romeike B, Moringlane JR, Schwechheimer K, Feiden W, Pfreundschuh M. 2000. Expression of cancer testis genes in human brain tumors. Clin Cancer Res 6:3916-3922.
138. Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, Verdi JM, Barker PA. 2000. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 27:279-288.
139. Sasaki M, Nakahira K, Kawano Y, Katakura H, Yoshimine T, Shimizu K, Kim SU, Ikenaka K. 2001. MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma. Cancer Res 61:4809-4814.
140. Satie AP, Rajpert-De Meyts E, Spagnoli GC, Henno S, Olivo L, Jacobsen GK, Rioux-Leclercq N, Jegou B, Samson M. 2002. The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. Lab Invest 82:775-780.
141. Scanlan MJ, Altorki NK, Gure AO, Williamson B, Jungbluth A, Chen YT, Old LJ. 2000. Expression of cancer-testis antigens in lung cancer: Definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9. Cancer Lett 150:155-164.
142. Scanlan MJ, Gordon CM, Williamson B, Lee SY, Chen YT, Stockert E, Jungbluth A, Ritter G, Jager D, Jager E, Knuth A, Old LJ. 2002. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 98:485-492.
143. Schultz TE, Noppen C, Gudat F, Durmuller U, Zajac P, Kocher T, Heberer M, Spagnoli GC. 2000. NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens. Br J Cancer 83:204-208.
144. Schultze JL, Vonderheide RH. 2001. From cancer genomics to cancer immunotherapy: Toward second-generation tumor antigens. Trends Immunol 22:516-523.
145. Seliger B, Maeurer MJ, Ferrone S. 2000. Antigen-processing machinery breakdown and tumor growth. Immunol Today 21:455-464.
146. Serrano A, Tanzarella S, Lionello I, Mendez R, Traversari C, Ruiz-Cabello F, Garrido F. 2001. Reexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2′-deoxycytidine treatment. Int J Cancer 94:243-251.
147. Shan J, Yuan L, Xiao Q, Chiorazzi N, Budman D, Teichberg S, Xu HP. 2002. TSP50, a possible protease in human testes, is activated in breast cancer epithelial cells. Cancer Res 62:290-294.
148. Shiras A, Sengupta A, Shepal V. 2001. Cloning and tissue-specific gene expression studies with dlxin-1, a newly identified transcriptional activator. Mol Cell Biol Res Commun 4:313-319.
149. Sigalotti L, Coral S, Altomonte M, Natali L, Gaudino G, Cacciotti P, Libener R, Colizzi F, Vianale G, Martini F, Tognon M, Jungbluth A, Cebon J, Maraskovsky E, Mutti L, Maio M. 2002a. Cancer testis antigens expression in mesothelioma: Role of DNA methylation and bioimmunotherapeutic implications. Br J Cancer 86:979-982.
150. Sigalotti L, Coral S, Nardi G, Spessotto A, Cortini E, Cattarossi I, Colizzi F, Altomonte M, Maio M. 2002b. Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma. J Immunother 25:16-26.
151. Soubrane C, Mouawad R, Antoine EC, Verola O, Gil DM, Khayat D. 2000. A comparative study of Fas and Fas-ligand expression during melanoma progression. Br J Dermatol 143:307-312.
152. Soulez M, Saurin AJ, Freemont PS, Knight JC. 1999. SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex. Oncogene 18:2739-2746.
153. Steger K. 2001. Haploid spermatids exhibit translationally repressed mRNAs. Anat Embryol (Berl) 203:323-334.
154. Stein GS, Montecino M, van Wijnen AJ, Stein JL, Lian JB. 2000. Nuclear structure-gene expression interrelationships: Implications for aberrant gene expression in cancer. Cancer Res 60:2067-2076.
155. Stevanovic S. 2002. Identification of tumour-associated t-cell epitopes for vaccine development. Nat Rev Cancer 2:514.
156. Stone B, Schummer M, Paley PJ, Crawford M, Ford M, Urban N, Nelson BH. 2001. MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily. Gene 267:173-182.
157. Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, van Pel A, de Plaen E, Amar-Costesec A, Boon T. 1992. A non-apeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 176:1453-1457.
158. Tureci O, Sahin U, Schobert I, Koslowski M, Scmitt H, Schild HJ, Stenner F, Seitz G, Rammensee HG, Pfreundschuh M. 1996. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 56:4766-4772.
159. Tureci O, Sahin U, Pfreundschuh M. 1997. Serological analysis of human tumor antigens: Molecular definition and implications. Mol Med Today 3:342-349.
160. Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. 1998. Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 95:5211-5216.
161. Tureci O, Sahin U, Koslowski M, Buss B, Bell C, Ballweber P, Zwick C, Eberle T, Zuber M, Villena-Heinsen C, Seitz G, Pfreundschuh M. 2002. A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing. Oncogene 21:3879-3888.
162. Ueda R, Shiku H, Pfreundschuh M, Takahashi T, Li LT, Whitmore WF, Oettgen HF, Old LJ. 1979. Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med 150:564-579.
163. van den Eynde B, Peeters O, de Backer O, Gaugler B, Lucas S, Boon T. 1995. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182:689-698.
164. van der Bruggen P, Traversari C, Chomez P, Lurquin C, de Plaen E, van den Eynde B, Knuth A, Boon T. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643-1647.
165. Walker WH, Delfino FJ, Habener JF. 1999. RNA processing and the control of spermatogenesis. Front Horm Res 25:34-58.
166. Wang RF, Rosenberg SA. 1996. Human tumor antigens recognized by T lymphocytes: Implications for cancer therapy. J Leukoc Biol 60: 296-309.
167. Wang RF, Parkhurst MR, Kawakami Y, Robbins PF, Rosenberg SA. 1996. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J Exp Med 183: 1131-1140.
168. Wang RF, Johnston SL, Zeng G, Topalian SL, Schwartzentruber DJ, Rosenberg SA. 1998. Abreast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames. J Immunol 161:3598-3606.
169. Wang RF, Wang X, Rosenberg SA. 1999. Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells. J Exp Med 189:1659-1668.
170. Wang PJ, McCarrey JR, Yang F, Page DC. 2001a. An abundance of X-linked genes expressed in spermatogonia. Nat Genet 27:422-426.
171. Wang T, Fan L, Watanabe Y, McNeill P, Fanger GR, Persing DH, Reed SG. 2001b. L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma. Oncogene 20:7699-7709.
172. Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF. 2002. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 169:1102-1109.
173. Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J, Rosenberg SA. 1994. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine. Cancer Res 54:1766-1771.
174. Wen Y, Richardson RT, Widgren EE, O'Rand MG. 2001. Characterization of Sp17: A ubiquitous three domain protein that binds heparin. Biochem J 357:25-31.
175. Westbrook VA, Diekman AB, Klotz KL, Khole VV, von Kap HC, Golden WL, Eddy RL, Shows TB, Stoler MH, Lee CYG, Flickinger CJ, Herr JC. 2000. Spermatid-specific expression of the novel X-linked gene product SPAN-X localized to the nucleus of human spermatozoa. Biol Reprod 63:469-481.
176. Westbrook VA, Diekman AB, Naaby HS, Coonrod SA, Klotz KL, Thomas TS, Norton EJ, Flickinger CJ, Herr JC. 2001. Differential nuclear localization of the cancer/testis-associated protein, SPAN-X/CTpll, in transfected cells and in 50% of human spermatozoa. Biol Reprod 64:345-358.
177. Yang D, Nakao M, Shichijo S, Sasatomi T, Takasu H, Matsumoto H, Mori K, Hayashi A, Yamana H, Shirouzu K, Itoh K. 1999. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients. Cancer Res 59:4056-4063.
178. Yuasa T, Okamoto K, Kawakami T, Mishina M, Ogawa O, Okada Y. 2001. Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue. J Urol 165:1790-1794.
179. Zendman AJ, Cornelissen IM, Weidle UH, Ruiter DJ, van-Muijen GN. 1999. CTp11, a novel member of the family of human cancer/testis antigens. Cancer Res 59:6223-6229.
180. Zendman AJ, de Wit NJ, van Kraats AA, Weidle UH, Ruiter DJ, van Muijen GN. 2001. Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma. Melanoma Res 11:451-459.
181. Zendman AJ, van Kraats AA, den Hollander AI, Weidle UH, Ruiter DJ, van Muijen GN. 2002a. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis. Int J Cancer 97:195-204.
182. Zendman AJ, van Kraats AA, Weidle UH, Ruiter DJ, van Muijen GN. 2002b. The XAGE family of cancer/testis-associated genes: Alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma. Int J Cancer 99:361-369.
183. Zendman AJ, Zschocke J, van Kraats AA, Kurpisz M, Weidle UH, Ruiter DJ, Weiss EH, van Muijen GN. 2003. The human SPANX multigene family: Genomic organization, alignment and expression in male germ cells and tumor cell lines. Submitted.